MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-13-2024
Country |
 USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
1.12 M |
Market Cap[1] |
$ 3.64 M |
EBITDA (LTM) |
$ -4.88 M |
P/E (LTM) |
- |
P/S (LTM) |
0.56 |
EPS (LTM) |
3.69 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Anika Therapeutics
ANIK
|
$ 14.93 | 0.88 % | $ 219 M | Nasdaq Global Select Market,SPB | USA |
 |
Aptorum Group Limited
APM
|
$ 0.93 | 0.51 % | $ 5.07 M | Nasdaq Global Select Market |  China |
 |
Aquestive Therapeutics
AQST
|
$ 4.14 | 0.36 % | $ 443 M | Nasdaq Global Market | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 8.39 | 4.5 % | $ 230 M | Nasdaq Global Market,SPB |  Israel |
 |
Ardelyx
ARDX
|
$ 6.06 | 1.94 % | $ 1.46 B | Nasdaq Global Market | USA |
 |
argenx SE
ARGX
|
$ 749.68 | 0.44 % | $ 25 B | Nasdaq Global Select Market |  Niderland |
 |
Arcutis Biotherapeutics
ARQT
|
$ 23.93 | 1.27 % | $ 3.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Arvinas
ARVN
|
$ 11.36 | 4.7 % | $ 805 M | Nasdaq Global Select Market,SPB | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | China |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 61.99 | 1.57 % | $ 8.29 B | Nasdaq Global Select Market,SPB | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |  France |
 |
Assembly Biosciences
ASMB
|
$ 29.09 | 0.28 % | $ 326 M | Nasdaq Global Select Market,SPB | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Actinium Pharmaceuticals
ATNM
|
$ 1.13 | 15.26 % | $ 35.3 M | NYSE American | USA |
 |
Atossa Therapeutics
ATOS
|
$ 5.19 | -3.36 % | $ 44.7 M | Nasdaq Capital Market | USA |
 |
Atara Biotherapeutics
ATRA
|
$ 5.0 | 0.2 % | $ 62.7 M | Nasdaq Global Select Market,SPB | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
$ 16.05 | 2.79 % | $ 2.16 B | Nasdaq Global Market |  Canada |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.41 | -0.35 % | $ 375 M | Nasdaq Global Select Market | Britain |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Axon Enterprise
AXON
|
$ 411.97 | -0.2 % | $ 31.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Aytu BioScience
AYTU
|
$ 2.65 | -1.12 % | $ 16.6 M | Nasdaq Capital Market | USA |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
BioCardia
BCDA
|
$ 1.18 | -1.67 % | $ 7.87 M | Nasdaq Global Select Market | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 9.59 | 6.26 % | $ 1.98 B | Nasdaq Global Select Market | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
$ 3.05 | 1.51 % | $ 260 M | Nasdaq Capital Market | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$ 9.46 | -3.47 % | $ 612 M | NYSE | USA |
 |
BioVie
BIVI
|
$ 1.46 | 2.81 % | $ 2.16 M | Nasdaq Capital Market | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 2.32 | 4.98 % | $ 908 M | Nasdaq Capital Market | Israel |
 |
BioMarin Pharmaceutical
BMRN
|
$ 56.04 | 0.96 % | $ 10.7 B | Nasdaq Global Select Market,SPB | USA |
 |
BioNTech SE
BNTX
|
$ 91.64 | 0.5 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
BioXcel Therapeutics
BTAI
|
$ 1.18 | -0.42 % | $ 14.4 M | Nasdaq Global Select Market,SPB | USA |
 |
Burford Capital Limited
BUR
|
$ 4.5 | 8.57 % | $ 683 M | NYSE | Britain |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.